12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Tuesday's after-market session. Reshape Lifesciences, MiMedx Group, Omnicell, NeuBase Therapeutics, Apollomics, and Tiziana Life Sciences saw gains, while Nevro, Penumbra, Adamis Pharmaceuticals, Compass Therapeutics, Meihua Intl Medical Techs, and RVL Pharmaceuticals experienced losses. Q2 earnings were released for MiMedx Group, Omnicell, Nevro, and Penumbra.
August 04, 2023 | 10:37 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Nevro stock decreased by 12.8% to $21.5 after Q2 earnings release.
The release of Q2 earnings likely contributed to the stock's decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Penumbra stock fell 9.5% to $270.0 after Q2 earnings release.
The release of Q2 earnings likely contributed to the stock's decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
MiMedx Group stock rose 8.44% to $8.6 after Q2 earnings release.
The release of Q2 earnings likely contributed to the stock's rise.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Omnicell stock moved upwards by 8.26% to $66.8 after Q2 earnings release.
The release of Q2 earnings likely contributed to the stock's rise.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Reshape Lifesciences stock rose 9.8% to $1.56.
The stock rose significantly in the after-market session, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100